MAITLAND, Fla., May 10, 2011 (GLOBE NEWSWIRE) -- Men's Medical Corporation (OTCBB:EMDH) announced today that as part of the Company's plan to offer a full range of men's health and lifestyle services, it has agreed to acquire through Saddleworth Ventures, LLC, pending the acceptance of financial audits 100% of:
Elite Professional IP Licensing Co.—License holder of the Boston Medical Group's name trademark, patents and license rights for the U.S.
Sound Management Group LLC—The operating entity for all of the services offered under the license.
Regional Professional Alliance Inc.— The entity managed by the Medical Directors and staff who will oversee the physicians and medical protocol for the Boston Medical Group clinics.
Two New Erectile Dysfunction Clinics—In addition to the three operating companies to be acquired, the transaction includes two new fully built out and staffed clinics in Scottsdale, AZ and Orlando, FL, both of which are scheduled to open within the next four weeks. Upon completion of the acquisition, the clinics will operate under the Boston Medical Group license.
Boston Medical Group History
For over fifteen years, Boston Medical Group (BMG) has operated in the United States a network of clinics run by independent physicians that treat Erectile Dysfunction (ED) and Premature Ejaculation (PE). BMG has treated hundreds of thousands of men during the past decade using "The Boston Method", a culmination of 15 years of experience developing the proprietary, personalized treatment process for ED and PE.
The "Boston Method"®
The Boston Method ® was developed utilizing fifteen years experience into treating sexual dysfunction. The Boston Method ® emphasizes three important factors: a private, confidential experience in the medical center, the evaluation of each patient's medical history, physical and diagnostic testing, and the determination of the most appropriate personalized treatment options specifically for each individual patient
Expanded Service Platform
Men's Medical Corporation is planning an expanded service platform creating new revenue channels to increase sales and profits in their BMG clinics.
Market Highlights
The U.S. market for men's sexual dysfunction therapies is expected to reach an estimated $2 billion by the end of 2011 and grow at 10% per year. 16% of all men aged 20-75 and 60% of men age 50-60 experience erection difficulties. 20% of all men suffer from premature ejaculation. The Massachusetts Male Aging Study has confirmed that 52% of the U.S. male population between the ages of forty and seventy suffers from some degree of impotence, with 10% of men suffering complete impotence.
Untapped Sexual Dysfunction Market
Dustin Moore ("Seeking Alpha" 2/23/11) wrote, "A monumental change is beginning to take shape across America. Starting this year, the first of the baby boomer generation will retire. The boomers, all 77 million of them, lived through great social change and numerous wars, but their biggest battle may be their health.
"One healthcare niche that is flying under the radar, but will greatly benefit from this development, is sexual dysfunction. Due to the "sensitivity" of the issue, sexual dysfunction is typically not a subject printed on the front page of the Sunday newspaper or a matter discussed at the work water cooler. But it is a hot topic at investment banking and hedge fund companies worldwide. That is because the sector represents one of the largest untapped growth markets in the biotech industry."
Intellectual Property Assets Acquired
Men's Medical Corporation has agreed to acquire through Saddleworth, Elite Professional IP Licensing, LLC., the U.S. BMG license holder for the use of certain proprietary, personalized treatment processes for erectile dysfunction and premature ejaculation, together with other protected marks, trade names and patents associated with men's health and lifestyle management. The IP Assets acquired include:
License:
Boston Medical Group U.S. license to own, operate and manage BMG clinics in the United States.
Trademarks:
The following trademarks were acquired in the transaction:
- Mark—SEX FOR LIFE—Reg. No. 2,674,911
- Mark—SEX IS LIFE—Reg. No. 2,692,837
- Mark—BOSTON MEDICAL GROUP & DESIGN—Serial No. 76/389,875
- Mark—The Boston Method—Serial No. 79/402,536
Intellectual Property:
All unregistered trademarks, trade names, slogan, logos and Copyright Registration for BMG Software Program.
Patent Rights and Know How Acquired:
For over ten years Boston Medical Group's network of independent physicians in the U.S. have used a personalized proprietary treatment program that enable most men to see results within minutes. In the acquisition of Elite, Men's Medical acquired:
- U.S. Utility Application Serial No. 10/351,04
METHOD AND COMPOSITION FOR TREATING MALE ERECTILE
DYSFUNCTION. Filed: January 24, 2003
- PCT/US Application Serial No. PCT/US 03/02082
METHOD AND COMPOSITION FOR TREATING MALE ERECTILE
DYSFUNCTION. International Filing Date: January 24, 2003
- U.S. Patent No. 7,405,222 B2
For: Methods & Compositions for Treatment of Erectile Dysfunction
Date of Patent: July 29, 2008
Further Erectile Dysfunction Market Highlights
The National Institutes of Health
Estimates of the number of American men who suffer from erectile dysfunction range from 15 to 30 million. Researchers estimate that roughly half of men over age 60 have ED.
The New York Times 4/14/11
The market for drugs to correct erectile dysfunction has passed $5 billion a year from sales to tens of million of men.
John Hopkins Bloomberg School of Public Health
More than 18 million men in the United States over age 20 are affected by erectile dysfunction.
Further Premature Ejaculation Market Highlights
Urology Channel--HealthCommunities.com
Premature ejaculation (PE) is a term used to describe a condition in which a man regularly ejects semen very soon after the onset of sexual arousal or sooner than he or his partner wishes. The condition, which is also called rapid ejaculation, is the most common type of sexual dysfunction in men under the age of 40.
Premature Ejaculation affects males only and can occur at any age of adulthood. The condition is most common between the ages of 18 and 30. It is estimated that premature ejaculation affects from 30-70% of men during their lifetime.
"Prevalence of Premature Ejaculation" Francesco Montorsi, MD
PE affects 25-60% of men in the United States.
Recent Men's Medical Corporation News
2/24/11 Men's Medical Corporation Secures Funding Commitment for Second Clinic in 30 Clinic Agreement
2/17/11 Men's Medical Corporation Secures Funding on First of 30 Clinic Agreement
2/7/11 Men's Medical Corporation Signs Agreement to Open Thirty Clinics
For more information please visit:
Forward-Looking Statements
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements (within the meaning of Section 27a of the Securities Act of 1933 and Section 21e of the Securities Exchange Act of 1934) regarding us and our business, financial condition, results of operations and prospects. Forward-looking statements in this report reflect the good-faith judgment of our management and the statements are based on facts and factors as we currently know them. Forward-looking statements are subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of the press release. Political and operational risks in the countries in which Emerging Media Holdings, Inc. may operate and governmental regulation and judicial outcomes, and other risks detailed from time to time in Emerging Media's filings with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended March 31, 2009. Copies of each filing may be obtained from Emerging Media Holdings or the S.E.C. or its web site at www.sec.gov.
CONTACT: Investor Relations: Christian Tedrow (407) 921-7032